future glp-1 drugs The New Weight Management Meds GLP-1 Drugs: Fighting Diabetes and

In the most recent American Association of Clinical Endocrinology clinical practice guidelines for the diagnosis and management of NAFLD it was recommended to administer pioglitazone (PIO) or glucagon-like peptide 1 receptor (GLP-1R) agonists with proven benefit for patients with T2D and biopsy-proven NASH, while these medications should be considered when there is high probability of having NASH (based on higher plasma aminotransferase levels and non-invasive tests) [40]

Overall, these factors solidified Tremfyas position as a leading therapy in the immunology market

Peng KL, et al

*Correspondence: Yi Zhang, [email protected]

Help with Prior Authorizations for GLP-1 Medications: Dealing with insurance can be complex, especially when it comes to prior authorizations for specific medications like GLP-1s